Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection

Microbiology

Volumn 144, Issue 8, 1998, Pages 2291-2298

  Londoño, Patricia ^a,c   Gao, Xiao M ^a   Bowe, Frances ^a   McPheat, William L ^b   Booth, George ^b   Dougan, Gordon ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c Peptide Therapeutics Ltd   (United Kingdom)

Author keywords

Candida albicans; Cytokines; Fungal infection; Immunity; In vivo animal models

Indexed keywords

FUNGUS ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; EXPERIMENTAL INFECTION; FUNGUS IMMUNITY; IMMUNE RESPONSE; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN CELL;

EID: 0031664176     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-144-8-2291     Document Type: Article

References (43)

1. Abbas, A. K., Murphy, K. M. & Sher, A. (1996). Functional diversity of helper T-lymphocytes. Nature 383, 787-793.
2. Ashman, R. B., Kay, P. H., Lynch, D. M. & Papadimitriou, J. M. (1991). Murine candidiasis : sex differences in the severity of tissue lesions are not associated with levels of C3 and C5. Immunol Cell Biol 69, 7-10.
3. Ashman, R. B., Bolitho, E. M. & Papadimitriou, J. M. (1993). Patterns of resistance to Candida albicans in inbred mouse strains. Immunol Cell Biol 71, 221-225.
4. Barry, E. M., Gomez-Duarte, O., Chatfield, S., Rappuoli, R., Pizza, M., Losonsky, G., Galen, J. & Levine, M. M. (1996). Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusion in Salmonella typhi vaccine strain CVD908. Infect Immun 64, 4172-181.
5. Barzu, S., Fontaine, A., Sansonetti, P. & Phalipou, A. (1996). Induction of a local anti-Ipa C antibody response in mice by use of a Shigella flexneri 2a vaccine candidate : implications for use of IpaC as a protein carrier. Infect Immun 64, 1190-1196.
6. Bistoni, F., Cenci, E., Mencacci, A., Schiaffella, E., Mosci, P., Puccetti, P. & Romani, L. (1993). Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis 168, 1449-1457.
7. Cenci, E., Mencacci, A., Spaccapelo, R., Tonnetti, L, Mosci, P., Enssle, K. H., Puccetti, P., Romani, L. & Bistoni, F. (1995). T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 171, 1279-1288.
8. Chakir, J., Cote, L., Coulombe, C. & Deslauriers, N. (1994). Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol 9, 88-94.
9. Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R. & Dougan, G. (1995). Mutants of E. coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic mucosal adjuvants. Proc Natl Acad Sci USA 92, 1644-1648.
10. Dupont, P. F. (1995). Candida albicans, the opportunist. A cellular and molecular perspective. J Am Podiatr Med Assoc 85, 104-115.
11. Elson, C. O., Ealding, W. & Lefkowitz, J. (1984). A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods 67, 101-108.
12. Fallen, K., Bausch, K., Noonan, J., Huguenel, E. & Tamburini, P. (1997). Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 65, 551-556.
13. Fedorka-Cray, P. J., Kelley, L. C., Stabel, T. J., Gray, J. T. & Laufer, J. A. (1995). Alternate routes of invasion may affect pathogenesis of Salmonella typhimurium in swine. Infect Immun 63, 2658-2664.
14. Galen, J. E., Gomez-Duarte, O. G., Losonsky, G. A., Halpern, J. L., Lauderbaugh, C. S., Kalmuck, S., Reymann, M. K. & Levine, M. M. (1997). A murine model of intranasal immunisation to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Vaccine 15, 700-708.
15. Gray, J. T., Fedorka-Cray, P. J., Stabel, T. J. & Ackermann, M. R. (1995). Influence of inoculation route on the carrier state of Salmonella choleraesuis in swine. Vet Microbiol 47, 43-59.
16. Greenfield, R. A. & Joyce, W. A. (1993). Gastric colonization with Candida albicans. Mycopathologia 122, 1-5.
17. Hector, R. F., Domer, J. E. & Carrow, E. W. (1982). Immune responses to Candida albicans in genetically distinct mice. Infect Immun 38, 1020-1028.
18. Heistrom, P. B. & Balish, E. (1979). Effect of oral tetracycline, the microbial flora, and the athymic state on gastrointestinal colonization and infection of BALB/c mice with Candida albicans. Infect Immun 23, 764-774.
19. Hurley, R. (1966). Effect of route of entry of Candida albicans on the histogenesis of the lesions in experimental candidosis in the mouse. J Pathol Bacteriol 92, 578-583.
20. Jensen, J., Warner, T. & Balish, E. (1993). Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J Infect Dis 167, 912-919.
21. Jensen, J., Warner, T. & Balish, E. (1994). The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J Infect Dis 170, 900-905.
22. Jensen, J., Warner, T., Johnson, C. & Balish, E. (1996). Oral immunization of mice against candidiasis. J Infect Dis 174, 133-140.
23. Klein, R. S., Harris, C. A., Small, C. B., Moll, B., Lesser, M. & Friedland, G. H. (1984). Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311, 354-358.
24. Klingspor, L., Stintzing, G., Fasth, A. & Tollemar, J. (1996). Deep Candida infection in children receiving allogeneic bone marrow transplants : incidence, risk factors and diagnosis. Bone Marrow Transplant 17, 1043-1049.
25. Lacasse, M., Fortier, C., Chakir, J., Cote, L. & Deslauriers, N. (1993). Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans. Oral Microbiol Immunol 8, 313-318.
26. Mallett, C. P., Van de Verg, L., Collins, H. H. & Hale, T. L. (1993). Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine 11, 190-196.
27. Mallett, C. P., Hale, T. L., Kaminski, R. W., Larsen, T., Orr, N., Cohen, D. & Lowell, G. H. (1995). Intranasal or intragastric immunisation with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection. Infect Immun 63, 2382-2386.
28. Noriega, F. R., Losonsky, G., Lauderbaugh, C., Liao, F. M., Wang, J. Y. & Levine, M. (1996). Engineered ΔguaBA ΔvirG Shigella flexneri 2a strain CVD1205 : construction, safety, immunogenicity and potential efficacy as a mucosal vaccine. Infect Immun 64, 3055-3061.
29. Nuget, K. M. & Onofrio, J. M. (1983). Pulmonary tissue resistance to Candida albicans in normal and immunosuppressed mice. Am Rev Respir Dis 128, 909-914.
30. Papadimitriou, J. M. & Ashman, R. B. (1986). The pathogenesis of acute systemic candidiasis in a susceptible inbred mouse strain. J Pathol 150, 257-265.
31. Pfaller, M. A. (1996). Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22, S89-S94.
32. Phalipon, A., Kaufmann, M., Michetti, P., Cavaillon, J., Huerre, M., Sansonetti, P. & Kraehenbuhl, J. P. (1995). Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med 182, 769-778.
33. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Mosci, P., Puccetti, P. & Bistoni, F. (1993). CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 150, 925-931.
34. Romani, L. Cenci, E., Menacci, A., Bistoni, F. & Puccetti, P. (1995). T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design. Immunol Res 14, 148-162.
35. Roof, M. B. & Doitchinoff, D. D. (1995). Safety, efficacy and duration of immunity induced in swine by use of an avirulent live Salmonella choleraesuis-containing vaccine. Am J Vet Res 56, 39-44.
36. Samaranayake, L. P. & Holmstrop, P. (1989). Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 18, 554-564.
37. Samonis, G., Dassiou, M. & Anastassiadou, H. (1994). Antibiotics affecting colonisation of mice by yeasts. J Chemother 6, 50-52.
38. Sawyer, R. T. (1990). Experimental pulmonary candidiasis. Mycopathologia 109, 99-109.
39. Sizemore, D. R., Bramstrom, A. A. & Sadoff, J. C. (1997). Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunisation. Vaccine 15, 804-807.
40. Stabel, T. J., Fedorka-Cray, P. J. & Gray, J. T. (1995). Tumour necrosis factor-α production in swine after oral or respiratory challenge exposure with live Salmonella typhimurium or Salmonella choleraesuis. Am J Vet Res 56, 1012-1018.
41. van de Verg, L. L., Mallet, C. P., Collins, H. H., Larsen, T., Hammack, C. & Hale, T. L. (1995). Antibody and cytokine response in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect Immun 63, 1947-1954.
42. Voino-Yasenetsky, M. V. & Voino-Yasenetsky, M. K. (1962). Experimental pneumonia caused by bacteria of the Shigella group. Acta Morphol Acad Sci Hung 11, 439-454.
43. Welkos, S. & O'Brien, A. (1994). Determination of median lethal and infectious doses in animal model systems. In Bacterial Pathogenesis, pp. 29-39. Edited by V. L. Clark & P. M. Bavoil. London: Academic Press.